Literature DB >> 26796305

The Functions of Histone Modification Enzymes in Cancer.

Ruilin Wang, Mei Xin, Yanjiao Li, Pingyu Zhang, Meixia Zhang1.   

Abstract

Posttranslational modifications of proteins critically regulate the function, localization, and stability of target proteins. Histone modification is one of the regulatory mechanisms that modulate the chromatin structure and thereby affect various DNA-templated processes, such as gene transcription, DNA replication, DNA recombination, and DNA repair in cells. These molecular processes contribute to basic cellular functions, including cell cycle, cell growth, and apoptosis. Histone modifications consist of acetylation, methylation, phosphorylation, ubiquitination, sumoylation biotination, citrullination, poly-ADPribosylation, and N-glycosylation. The modification status of histone is balanced by two enzyme families with opposing catalytic activities: histone modifying and de-modifying enzymes. Recent studies have shown that dysfunction of histone modification enzymes is a major cause for human cancer initiation and progression. In this review, we will summarize the functions of histone modification enzymes in cancer, and the mechanisms that histone modification enzymes use to drive or suppress human malignancies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26796305     DOI: 10.2174/1389203717666160122120521

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  11 in total

Review 1.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

2.  A Novel Histone Crosstalk Pathway Important for Regulation of UV-Induced DNA Damage Repair in Saccharomyces cerevisiae.

Authors:  Anna L Boudoures; Jacob J Pfeil; Elizabeth M Steenkiste; Rachel A Hoffman; Elizabeth A Bailey; Sara E Wilkes; Sarah K Higdon; Jeffrey S Thompson
Journal:  Genetics       Date:  2017-05-18       Impact factor: 4.562

3.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

4.  p300/Sp1-Mediated High Expression of p16 Promotes Endothelial Progenitor Cell Senescence Leading to the Occurrence of Chronic Obstructive Pulmonary Disease.

Authors:  Zhihui He; Huaihuai Peng; Min Gao; Guibin Liang; Menghao Zeng; Xuefeng Zhang
Journal:  Mediators Inflamm       Date:  2021-08-19       Impact factor: 4.711

Review 5.  Epigenetics in Congenital Heart Disease.

Authors:  Guanglei Wang; Bingbing Wang; Peixin Yang
Journal:  J Am Heart Assoc       Date:  2022-03-29       Impact factor: 6.106

6.  Association between H3K4 methylation and cancer prognosis: A meta-analysis.

Authors:  Simin Li; Luyan Shen; Ke-Neng Chen
Journal:  Thorac Cancer       Date:  2018-05-08       Impact factor: 3.500

Review 7.  EZH2: a novel target for cancer treatment.

Authors:  Ran Duan; Wenfang Du; Weijian Guo
Journal:  J Hematol Oncol       Date:  2020-07-28       Impact factor: 17.388

8.  p300-Catalyzed Lysine Crotonylation Promotes the Proliferation, Invasion, and Migration of HeLa Cells via Heterogeneous Nuclear Ribonucleoprotein A1.

Authors:  Xuesong Han; Xudong Xiang; Hongying Yang; Hongping Zhang; Shuang Liang; Jie Wei; Jing Yu
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-07       Impact factor: 2.916

Review 9.  The Relevance of Gender in Tumor-Influencing Epigenetic Traits.

Authors:  Victoria Sarne; Sandrina Braunmueller; Lisa Rakob; Rita Seeboeck
Journal:  Epigenomes       Date:  2019-01-28

10.  miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.

Authors:  Yunze Dong; Yuchen Gao; Tiancheng Xie; Huan Liu; Xiangcheng Zhan; Yunfei Xu
Journal:  Biomed Res Int       Date:  2021-07-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.